No.92：公共の場でのマスクの感染予防効果／レナカパビルによるHIV予防治療【Podcast：にゃんごう＆いがさんのEBMerな夜】

No.92：公共の場でのマスクの感染予防効果／レナカパビルによるHIV予防治療

にゃんごう＆いがさんのEBMerな夜
第92回放送　2024/7/30

【にゃんごう：公共の場でのマスクの感染予防効果】
Solberg RB, Fretheim A, Elgersma IH, Fagernes M, Iversen BG, Hemkens LG, Rose CJ, Elstrom P.
Personal protective effect of wearing surgical face masks in public spaces on self-reported respiratory symptoms in adults: pragmatic randomised superiority trial.
BMJ. 2024 Jul 24;386:e078918. doi: 10.1136/bmj-2023-078918.
PMID: 39048132; PMCID: PMC11267995.
https://www.bmj.com/content/386/bmj-2023-078918

【いがさん：レナカパビルによるHIV予防治療】
Bekker LG, Das M, Abdool Karim Q, Ahmed K, Batting J, Brumskine W, Gill K, Harkoo I, Jaggernath M, Kigozi G, Kiwanuka N, Kotze P, Lebina L, Louw CE, Malahleha M, Manentsa M, Mansoor LE, Moodley D, Naicker V, Naidoo L, Naidoo M, Nair G, Ndlovu N, Palanee-Phillips T, Panchia R, Pillay S, Potloane D, Selepe P, Singh N, Singh Y, Spooner E, Ward AM, Zwane Z, Ebrahimi R, Zhao Y, Kintu A, Deaton C, Carter CC, Baeten JM, Matovu Kiweewa F; PURPOSE 1 Study Team.
Twice-Yearly Lenacapavir or Daily F/TAF for HIV Prevention in Cisgender Women.
N Engl J Med. 2024 Jul 24. doi: 10.1056/NEJMoa2407001. Epub ahead of print.
PMID: 39046157.
https://www.nejm.org/doi/full/10.1056/NEJMoa2407001

リスナーアンケートにご協力下さい！！
https://goo.gl/forms/5AsPilK7QnB9VrmX2